A rational approach to the evaluation and management of patients with hyperprolactinemia

被引:1
作者
Aldahmani, Khaled M. [1 ,2 ]
AlMalki, Mussa H. [3 ,4 ]
Beshyah, Salem A. [5 ,6 ]
机构
[1] Tawam Hosp, Dept Endocrinol, Al Ain, U Arab Emirates
[2] UAE Univ, Coll Med & Hlth Sci, Dept Med, Al Ain, U Arab Emirates
[3] King Fahad Med City, Obes Endocrine & Metab Ctr, Riyadh, Saudi Arabia
[4] King Saud Bin Abdul Aziz Univ Hlth Sci, Fac Med, Dept Med, Riyadh, Saudi Arabia
[5] Dubai Med Coll, Dept Med, Abu Dhabi, U Arab Emirates
[6] Mediclin Airport, Dept Endocrinol, Abu Dhabi, U Arab Emirates
来源
IBNOSINA JOURNAL OF MEDICINE AND BIOMEDICAL SCIENCES | 2020年 / 12卷 / 02期
关键词
Cabergoline; hyperprolactinemia; pituitary tumors; prolactin; PITUITARY-ADENOMAS; PROLACTINOMAS; DIAGNOSIS; RADIOSURGERY; MULTICENTER; PREVALENCE; RESISTANT; EFFICACY; SURGERY; THERAPY;
D O I
10.4103/ijmbs.ijmbs_38_20
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prolactin has multiple biological functions. Hyperprolactinemia is a common condition in clinical practice both in women and men. It has multiple etiologies and may present with variable symptoms to different health-care providers. Therefore, a rational and systematic approach is paramount when evaluating patients with hyperprolactinemia to arrive at the correct diagnosis and institute the appropriate therapy. We here review the etiology, clinical presentation, and differential diagnosis of hyperprolactinemia and present a practical plan for further evaluation and management. It is most essential to establish the diagnosis and need for the treatment of patients with micro- and macro-prolactinomas and identify when only observation may be warranted. The biological, medical, and social contexts have to be considered to make the appropriate management decisions on an individual basis.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 46 条
  • [1] Prevalence and risk factors of hyperprolactinemia among patients with various psychiatric diagnoses and medications
    Alosaimi, Fahad D.
    Fallata, Ebtihaj O.
    Abalhassan, Mohammed
    Alhabbad, Abdulhadi
    Alzain, Nasser
    Alhaddad, Bandar
    Alassiry, Mohammed Z.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2018, 22 (04) : 274 - 281
  • [2] Prolactin - a pleiotropic factor in health and disease
    Bernard, Valerie
    Young, Jacques
    Binart, Nadine
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (06) : 356 - 365
  • [3] Management of prolactinomas: a survey of physicians from the Middle East and North Africa
    Beshyah, Salem A.
    Sherif, Ibrahim H.
    Chentli, Farida
    Hamrahian, Amir
    Khalil, Aly B.
    Raef, Hussein
    El-Fikki, Mohamed
    Jambart, Selim
    [J]. PITUITARY, 2017, 20 (02) : 231 - 240
  • [4] Impulse control disorders in patients with prolactinoma receiving dopamine agonist therapy: a prospective study with 1 year follow-up
    Celik, Emir
    Ozkaya, Hande Mefkure
    Poyraz, Burc Cagri
    Saglam, Tarik
    Kadioglu, Pinar
    [J]. ENDOCRINE, 2018, 62 (03) : 692 - 700
  • [5] The prolactinoma
    Colao, Annamaria
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (05) : 575 - 596
  • [6] Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
    Dekkers, Olaf M.
    Lagro, Joep
    Burman, Pia
    Jorgensen, Jens Otto
    Romijn, Johannes A.
    Pereira, Alberto M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01) : 43 - 51
  • [7] PCOS and Hyperprolactinemia: what do we know in 2019?
    Delcour, Clemence
    Robin, Geoffroy
    Young, Jacques
    Dewailly, Didier
    [J]. CLINICAL MEDICINE INSIGHTS-REPRODUCTIVE HEALTH, 2019, 13
  • [8] Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males
    Di Somma, C
    Colao, A
    Di Sarno, A
    Klain, M
    Landi, ML
    Facciolli, G
    Pivonello, R
    Panza, N
    Salvatore, M
    Lombardi, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) : 807 - 813
  • [9] Determination of prolactin: The macroprolactin problem
    Fahie-Wilson, Michael
    Smith, Thomas P.
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 27 (05) : 725 - 742
  • [10] Unusual causes of sellar/parasellar masses in a large transsphenoidal surgical series
    Freda, PU
    Wardlaw, SL
    Post, KD
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) : 3455 - 3459